08:00 , Feb 23, 2012 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine/metabolic disease Diabetes; obesity Family with sequence similarity 132 member A (FAM132A; CTRP12) A study in mice suggests CTRP12 could help treat obesity and type 2...